Download the presentation slides (PDF)
... basal ganglia, and hippocampus • Few cannabinoid receptors in the respiratory areas in brainstem • The cannabinoid receptors CB1 and CB2, two G protein-coupled receptors that are located in the central and peripheral nervous systems. ...
... basal ganglia, and hippocampus • Few cannabinoid receptors in the respiratory areas in brainstem • The cannabinoid receptors CB1 and CB2, two G protein-coupled receptors that are located in the central and peripheral nervous systems. ...
Cannabis can kill cancer cells and curb MS
... to make these sufficiently effective on the pain system without unwanted side effects.” The side effects from synthetic cannabis are the same as with natural cannabis: you get stoned, tired, unfocused, forgetful, and prolonged use can lead to depression and other mental disorders. This makes it dif ...
... to make these sufficiently effective on the pain system without unwanted side effects.” The side effects from synthetic cannabis are the same as with natural cannabis: you get stoned, tired, unfocused, forgetful, and prolonged use can lead to depression and other mental disorders. This makes it dif ...
Is cannabis addictive?
... Can you get addicted to cannabis? At one time, it was believed that cannabis didn’t have any addictive qualities. Even now, individuals still believe in the casual nature of marijuana. However, extensive research has highlighted just how addictive the substance can be, especially if it is used regul ...
... Can you get addicted to cannabis? At one time, it was believed that cannabis didn’t have any addictive qualities. Even now, individuals still believe in the casual nature of marijuana. However, extensive research has highlighted just how addictive the substance can be, especially if it is used regul ...
Cannabis and MS
... Request to move Marijuana to DEA Schedule II filed in 1972 -Hearings lasted from 1986 to 1988 -Affidavit filed by DJP, called to testify by DEA -Judge Young ruled that Marijuana should be reclassified as a Schedule II drug under CSA and made available for medical purposes (September 6, 1988) -DEA ig ...
... Request to move Marijuana to DEA Schedule II filed in 1972 -Hearings lasted from 1986 to 1988 -Affidavit filed by DJP, called to testify by DEA -Judge Young ruled that Marijuana should be reclassified as a Schedule II drug under CSA and made available for medical purposes (September 6, 1988) -DEA ig ...
Drugs, Society, and Human Behavior
... Complex and choice reaction time, accuracy but not speed affected. Impaired short-term memory Reduced sustained attention Impaired visuo-spatial and temporal processing ...
... Complex and choice reaction time, accuracy but not speed affected. Impaired short-term memory Reduced sustained attention Impaired visuo-spatial and temporal processing ...
syntheticcannibinoids
... patients who needed ER assistance after cannabis use was 30 years old, compared to SCRA use, the average age was 24 (DAWN, 2012). In another American study, 60% of SCRA overdose occurred in people under 25 years of age (AAPCC, 2012; Hu et al., 2011) and 57% were younger than 20 (Forrester, 2011). Ho ...
... patients who needed ER assistance after cannabis use was 30 years old, compared to SCRA use, the average age was 24 (DAWN, 2012). In another American study, 60% of SCRA overdose occurred in people under 25 years of age (AAPCC, 2012; Hu et al., 2011) and 57% were younger than 20 (Forrester, 2011). Ho ...
Driving Under the Influence of Drugs
... Overall the evidence suggests that cannabis impairs driving ability and increases a driver’s risk of being involved in a car crash. A number of studies have shown that cannabis affects memory, psychomotor abilities, reaction times and these effects remain long after the ‘high’ has passed. The percep ...
... Overall the evidence suggests that cannabis impairs driving ability and increases a driver’s risk of being involved in a car crash. A number of studies have shown that cannabis affects memory, psychomotor abilities, reaction times and these effects remain long after the ‘high’ has passed. The percep ...
Driving under the influence of drugs
... Overall the evidence suggests that cannabis impairs driving ability and increases a driver’s risk of being involved in a car crash. A number of studies have shown that cannabis affects memory, psychomotor abilities, reaction times and these effects remain long after the ‘high’ has passed. The percep ...
... Overall the evidence suggests that cannabis impairs driving ability and increases a driver’s risk of being involved in a car crash. A number of studies have shown that cannabis affects memory, psychomotor abilities, reaction times and these effects remain long after the ‘high’ has passed. The percep ...
The Effects of Drugs over time
... schizophrenia and a fourfold increase in major depression. There's a massive amount of evidence from as far apart as Sweden and New Zealand that cannabis actually causes these problems. Drugscope, a British drugs information service said cannabis may only precipitate schizophrenia in people who woul ...
... schizophrenia and a fourfold increase in major depression. There's a massive amount of evidence from as far apart as Sweden and New Zealand that cannabis actually causes these problems. Drugscope, a British drugs information service said cannabis may only precipitate schizophrenia in people who woul ...
THC
... Sensory perception seems enhanced, colours are brighter, sounds are more distinct. Sense of time and space is distorted. Appetite increases, especially for sweets. impaired coordination and balance, rapid heartbeat, red eyes, dry mouth and throat. Some experience hallucinations with larger doses and ...
... Sensory perception seems enhanced, colours are brighter, sounds are more distinct. Sense of time and space is distorted. Appetite increases, especially for sweets. impaired coordination and balance, rapid heartbeat, red eyes, dry mouth and throat. Some experience hallucinations with larger doses and ...
Cannabis
... • These three taxa are indigenous to Central Asia, and South Asia. • Importance of the classification from a legal point of view, only Cannabis sativa products were considered illegals. ...
... • These three taxa are indigenous to Central Asia, and South Asia. • Importance of the classification from a legal point of view, only Cannabis sativa products were considered illegals. ...
Problems Cannabis is not physically addictive but this
... Psychosis Long Term Side Effects As above Lethargy Lack of motivation ...
... Psychosis Long Term Side Effects As above Lethargy Lack of motivation ...
Document
... sativa, skunk, smoke, sticky icky, magic smoke, giggle smoke, I miss my mommy, etc. over 200 names to describe Marijuana ...
... sativa, skunk, smoke, sticky icky, magic smoke, giggle smoke, I miss my mommy, etc. over 200 names to describe Marijuana ...
B3a Worksheet 3: DNA
... Evaluate this investigation: consider the reliability, validity and usefulness of the study. _________________________________________________________________________________ _________________________________________________________________________________ ___________________________________________ ...
... Evaluate this investigation: consider the reliability, validity and usefulness of the study. _________________________________________________________________________________ _________________________________________________________________________________ ___________________________________________ ...
Medical cannabis
Medical cannabis, or medical marijuana, refers to the use of cannabis and its cannabinoids to treat disease or improve symptoms. The use of cannabis as a medicine has not been rigorously scientifically tested often due to restrictions on the production of the drug. There is limited evidence suggesting cannabis can be used to reduce nausea and vomiting during chemotherapy, to improve appetite in people with HIV/AIDS, and to treat chronic pain and muscle spasms. Its use for other medical applications is insufficient for conclusions about safety or efficacy.Short-term use increases both minor and major adverse effects. Common side effects include dizziness, feeling tired, vomiting, and hallucinations. Long-term effects of cannabis are not clear. Concerns include memory and cognition problems, risk of addiction, schizophrenia in young people, and the risk of children taking it by accident.The Cannabis plant has a history of medicinal use dating back thousands of years across many cultures. Its current use is controversial. The American Medical Association, the Minnesota Medical Association, the American Society of Addiction Medicine, and other medical organizations have issued statements opposing its use for medicinal purposes. The American Academy of Pediatrics states that while cannabinoids may have potential as therapy for a number of medical conditions, they do not recommend it until more research is done. They, along with the American Medical Association and the Minnesota Medical Association, call for moving cannabis out of DEA Schedule I to facilitate this research.Medical cannabis can be administered using a variety of methods, including vaporizing or smoking dried buds, eating extracts, taking capsules or using oral sprays. Synthetic cannabinoids are available as prescription drugs in some countries; examples include: dronabinol and nabilone. Recreational use of cannabis is illegal in most parts of the world, but the medical use of cannabis is legal in certain countries, including Austria, Canada, Czech Republic, Finland, Germany, Israel, Italy, the Netherlands, Portugal and Spain. In the United States, federal law outlaws all cannabis use, while 20 states and the District of Columbia no longer prosecute individuals for the possession or sale of marijuana, as long as the individuals are in compliance with the state's marijuana sale regulations. However, an appeals court ruled in January 2014 that a 2007 Ninth Circuit ruling remains binding in relation to the ongoing illegality, in federal legislative terms, of Californian cannabis dispensaries, reaffirming the impact of the federal Controlled Substances Act.